glp 1 effects of thyroid horomones GLP-1 actions and target organs. GLP-1, through its receptor GLP-1R, GLP-1RA and thyroid cancer: New

Subsequently, liraglutide (Saxenda) was approved in 2014 for the treatment of obesity up to a maximum dose of 3.0 mg subcutaneously once daily in people with a BMI 30 kg/m 2 , or 27 kg/m 2 and obesity-related co-morbidity [9, 17]

Let's explore each medication and its uses

Across these studies, semaglutide 2.4 mg (the dose used for weight management) showed consistent and significant weight-loss results

Deboever N, Correa AM, Feldman H, Mathur U, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Antonoff MB, Rajaram R

This hormone is released by the gut after we eat and serves both to lower blood sugar (thus its use in type 2 diabetes) and provides a feeling of satisfaction